Viewing Study NCT06764368


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2025-12-25 @ 3:05 PM
Study NCT ID: NCT06764368
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-01-08
First Post: 2024-12-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors
Sponsor: Beijing Chest Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module